{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-diabetic drugs", "diabetes mellitus", "monoterpenes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35011414", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "29"}], "Language": ["eng"], "ELocationID": ["182", "10.3390/molecules27010182"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update.", "Abstract": {"AbstractText": ["Diabetes mellitus (DM) is a chronic metabolic condition characterized by persistent hyperglycemia due to insufficient insulin levels or insulin resistance. Despite the availability of several oral and injectable hypoglycemic agents, their use is associated with a wide range of side effects. Monoterpenes are compounds extracted from different plants including herbs, vegetables, and fruits and they contribute to their aroma and flavor. Based on their chemical structure, monoterpenes are classified into acyclic, monocyclic, and bicyclic monoterpenes. They have been found to exhibit numerous biological and medicinal effects such as antipruritic, antioxidant, anti-inflammatory, and analgesic activities. Therefore, monoterpenes emerged as promising molecules that can be used therapeutically to treat a vast range of diseases. Additionally, monoterpenes were found to modulate enzymes and proteins that contribute to insulin resistance and other pathological events caused by DM. In this review, we highlight the different mechanisms by which monoterpenes can be used in the pharmacological intervention of DM via the alteration of certain enzymes, proteins, and pathways involved in the pathophysiology of DM. Based on the fact that monoterpenes have multiple mechanisms of action on different targets in in vitro and in vivo studies, they can be considered as lead compounds for developing effective hypoglycemic agents. Incorporating these compounds in clinical trials is needed to investigate their actions in diabetic patients in order to confirm their ability in controlling hyperglycemia."]}, "AuthorList": [{"Identifier": ["0000-0002-8338-7655"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi P.O. Box 144534, United Arab Emirates."}], "LastName": "Al Kury", "ForeName": "Lina T", "Initials": "LT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq P.O. Box 15503, Bahrain."}], "LastName": "Abdoh", "ForeName": "Aya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq P.O. Box 15503, Bahrain."}], "LastName": "Ikbariah", "ForeName": "Kamel", "Initials": "K"}, {"Identifier": ["0000-0002-0320-1487"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zayed Center for Health Sciences, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi P.O. Box 144534, United Arab Emirates."}], "LastName": "Sadek", "ForeName": "Bassem", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Department, SEHA, Abu Dhabi Health Services, Abu Dhabi P.O. Box 144534, United Arab Emirates."}], "LastName": "Mahgoub", "ForeName": "Mohamed", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Monoterpenes"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Clinical Decision-Making"}, {"QualifierName": [], "DescriptorName": "Clinical Studies as Topic"}, {"QualifierName": ["drug therapy", "etiology", "metabolism"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Disease Susceptibility"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "etiology", "metabolism"], "DescriptorName": "Hyperglycemia"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Monoterpenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "American Diabetes Association 4. Lifestyle Management: Standards of Medical Care in Diabetes\u20142018. Diabetes Care. 2018;41((Suppl. 1)):S38\u2013S50. doi: 10.2337/dc18-S004.", "ArticleIdList": ["10.2337/dc18-S004", "29222375"]}, {"Citation": "American Diabetes Association Standards of medical care in diabetes--2014. Diabetes Care. 2014;37((Suppl. 1)):S14\u2013S80. doi: 10.2337/dc14-S014.", "ArticleIdList": ["10.2337/dc14-S014", "24357209"]}, {"Citation": "Adeghate E. Diabetes mellitus-multifactorial in aetiology and global in prevalence. Arch. Physiol. Biochem. 2001;109:197\u2013199. doi: 10.1076/apab.109.3.197.11588.", "ArticleIdList": ["10.1076/apab.109.3.197.11588", "11880920"]}, {"Citation": "Chiefari E., Arcidiacono B., Foti D., Brunetti A. Gestational diabetes mellitus: An updated overview. J. Endocrinol. Investig. 2017;40:899\u2013909. doi: 10.1007/s40618-016-0607-5.", "ArticleIdList": ["10.1007/s40618-016-0607-5", "28283913"]}, {"Citation": "Anik A., Catli G., Abaci A., Bober E. Maturity-onset diabetes of the young (MODY): An update. J. Pediatr. Endocrinol. Metab. 2015;28:251\u2013263. doi: 10.1515/jpem-2014-0384.", "ArticleIdList": ["10.1515/jpem-2014-0384", "25581748"]}, {"Citation": "American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;33((Suppl. 1)):S62\u2013S69.", "ArticleIdList": ["PMC2797383", "20042775"]}, {"Citation": "Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 1994;125:177\u2013188.", "ArticleIdList": ["8040759"]}, {"Citation": "Ahmed M.S., Khan A.U., Kury L.T.A., Shah F.A. Computational and Pharmacological Evaluation of Carveol for Antidiabetic Potential. Front. Pharmacol. 2020;11:919. doi: 10.3389/fphar.2020.00919.", "ArticleIdList": ["10.3389/fphar.2020.00919", "PMC7403477", "32848717"]}, {"Citation": "Zieli\u0144ska-B\u0142ajet M., Feder-Kubis J. Monoterpenes and Their Derivatives-Recent Development in Biological and Medical Applications. Int. J. Mol. Sci. 2020;21:7078. doi: 10.3390/ijms21197078.", "ArticleIdList": ["10.3390/ijms21197078", "PMC7582973", "32992914"]}, {"Citation": "\u00d6zbek H., Yilmaz B. Anti-inflammatory and hypoglycemic activities of alpha-pinene. ACTA Pharm. Sci. 2017;55:7. doi: 10.23893/1307-2080.APS.05522.", "ArticleIdList": ["10.23893/1307-2080.APS.05522"]}, {"Citation": "Habtemariam S. Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight. Int. J. Mol. Sci. 2017;19:4. doi: 10.3390/ijms19010004.", "ArticleIdList": ["10.3390/ijms19010004", "PMC5795956", "29267214"]}, {"Citation": "Salsali A., Nathan M. A Review of Types 1 and 2 Diabetes Mellitus and Their Treatment with Insulin. Am. J. Ther. 2006;13:349\u2013361. doi: 10.1097/00045391-200607000-00012.", "ArticleIdList": ["10.1097/00045391-200607000-00012", "16858171"]}, {"Citation": "Urakami T. Maturity-onset diabetes of the young (MODY): Current perspectives on diagnosis and treatment. Diabetes Metab. Syndr. Obes. 2019;12:1047\u20131056. doi: 10.2147/DMSO.S179793.", "ArticleIdList": ["10.2147/DMSO.S179793", "PMC6625604", "31360071"]}, {"Citation": "Lin X., Xu Y., Pan X., Xu J., Ding Y., Sun X., Song X., Ren Y., Shan P.F. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci. Rep. 2020;10:14790. doi: 10.1038/s41598-020-71908-9.", "ArticleIdList": ["10.1038/s41598-020-71908-9", "PMC7478957", "32901098"]}, {"Citation": "van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: Etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011;91:79\u2013118. doi: 10.1152/physrev.00003.2010.", "ArticleIdList": ["10.1152/physrev.00003.2010", "21248163"]}, {"Citation": "Gillespie K.M. Type 1 diabetes: Pathogenesis and prevention. CMAJ Can. Med. Assoc. J. J. L\u2019association Med. Can. 2006;175:165\u2013170. doi: 10.1503/cmaj.060244.", "ArticleIdList": ["10.1503/cmaj.060244", "PMC1489998", "16847277"]}, {"Citation": "Gerich J.E. Insulin-dependent diabetes mellitus: Pathophysiology. Mayo Clin. Proc. 1986;61:787\u2013791. doi: 10.1016/S0025-6196(12)64818-6.", "ArticleIdList": ["10.1016/S0025-6196(12)64818-6", "3528691"]}, {"Citation": "Chaudhury A., Duvoor C., Reddy Dendi V.S., Kraleti S., Chada A., Ravilla R., Marco A., Shekhawat N.S., Montales M.T., Kuriakose K., et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. 2017;8:6. doi: 10.3389/fendo.2017.00006.", "ArticleIdList": ["10.3389/fendo.2017.00006", "PMC5256065", "28167928"]}, {"Citation": "Goran M.I., Ball G.D., Cruz M.L. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J. Clin. Endocrinol. Metab. 2003;88:1417\u20131427. doi: 10.1210/jc.2002-021442.", "ArticleIdList": ["10.1210/jc.2002-021442", "12679416"]}, {"Citation": "Gilmartin A.B.H., Ural S.H., Repke J.T. Gestational Diabetes Mellitus. Rev. Obstet. Gynecol. 2008;1:129\u2013134.", "ArticleIdList": ["PMC2582643", "19015764"]}, {"Citation": "Amed S., Oram R. Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment. Can. J. Diabetes. 2016;40:449\u2013454. doi: 10.1016/j.jcjd.2016.03.002.", "ArticleIdList": ["10.1016/j.jcjd.2016.03.002", "27130141"]}, {"Citation": "Czech M.P. Insulin action and resistance in obesity and type 2 diabetes. Nat. Med. 2017;23:804\u2013814. doi: 10.1038/nm.4350.", "ArticleIdList": ["10.1038/nm.4350", "PMC6048953", "28697184"]}, {"Citation": "Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Investig. 1999;104:787\u2013794. doi: 10.1172/JCI7231.", "ArticleIdList": ["10.1172/JCI7231", "PMC408438", "10491414"]}, {"Citation": "Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet. 2005;365:1333\u20131346. doi: 10.1016/S0140-6736(05)61032-X.", "ArticleIdList": ["10.1016/S0140-6736(05)61032-X", "15823385"]}, {"Citation": "Chatterjee S., Khunti K., Davies M.J. Type 2 diabetes. Lancet. 2017;389:2239\u20132251. doi: 10.1016/S0140-6736(17)30058-2.", "ArticleIdList": ["10.1016/S0140-6736(17)30058-2", "28190580"]}, {"Citation": "Nyenwe E.A., Kitabchi A.E. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metab. Clin. Exp. 2016;65:507\u2013521. doi: 10.1016/j.metabol.2015.12.007.", "ArticleIdList": ["10.1016/j.metabol.2015.12.007", "26975543"]}, {"Citation": "Mar\u00edn-Pe\u00f1alver J.J., Mart\u00edn-Tim\u00f3n I., Sevillano-Collantes C., del Ca\u00f1izo-G\u00f3mez F.J. Update on the treatment of type 2 diabetes mellitus. World J. Diabetes. 2016;7:354\u2013395. doi: 10.4239/wjd.v7.i17.354.", "ArticleIdList": ["10.4239/wjd.v7.i17.354", "PMC5027002", "27660695"]}, {"Citation": "Weir M.R. The kidney and type 2 diabetes mellitus: Therapeutic implications of SGLT2 inhibitors. Postgrad. Med. 2016;128:290\u2013298. doi: 10.1080/00325481.2016.1147926.", "ArticleIdList": ["10.1080/00325481.2016.1147926", "26821720"]}, {"Citation": "Cai C., Qian L., Jiang S., Sun Y., Wang Q., Ma D., Xiao G., Li B., Xie S., Gao T., et al. Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs. Oncotarget. 2017;8:34911\u201334922. doi: 10.18632/oncotarget.16822.", "ArticleIdList": ["10.18632/oncotarget.16822", "PMC5471021", "28432282"]}, {"Citation": "Nigro E., Scudiero O., Ludovica Monaco M., Polito R., Schettino P., Grandone A., Perrone L., Miraglia Del Giudice E., Daniele A. Adiponectin profile and Irisin expression in Italian obese children: Association with insulin-resistance. Cytokine. 2017;94:8\u201313. doi: 10.1016/j.cyto.2016.12.018.", "ArticleIdList": ["10.1016/j.cyto.2016.12.018", "28385328"]}, {"Citation": "Qiu S., Cai X., Yin H., Zugel M., Sun Z., Steinacker J.M., Schumann U. Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis. Metab. Clin. Exp. 2016;65:825\u2013834. doi: 10.1016/j.metabol.2016.02.006.", "ArticleIdList": ["10.1016/j.metabol.2016.02.006", "27173461"]}, {"Citation": "Petersen K.F., Shulman G.I. Cellular mechanism of insulin resistance in skeletal muscle. J. R. Soc. Med. 2002;95((Suppl. 42)):8\u201313.", "ArticleIdList": ["PMC1308947", "12216329"]}, {"Citation": "Petersen K.F., Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 2002;90:11g\u201318g. doi: 10.1016/S0002-9149(02)02554-7.", "ArticleIdList": ["10.1016/S0002-9149(02)02554-7", "12231074"]}, {"Citation": "Satoh T. Molecular mechanisms for the regulation of insulin-stimulated glucose uptake by small guanosine triphosphatases in skeletal muscle and adipocytes. Int. J. Mol. Sci. 2014;15:18677\u201318692. doi: 10.3390/ijms151018677.", "ArticleIdList": ["10.3390/ijms151018677", "PMC4227239", "25325535"]}, {"Citation": "Galicia-Garcia U., Benito-Vicente A., Jebari S., Larrea-Sebal A., Siddiqi H., Uribe K.B., Ostolaza H., Mart\u00edn C. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 2020;21:6275. doi: 10.3390/ijms21176275.", "ArticleIdList": ["10.3390/ijms21176275", "PMC7503727", "32872570"]}, {"Citation": "Titchenell P.M., Lazar M.A., Birnbaum M.J. Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends Endocrinol. Metab. 2017;28:497\u2013505. doi: 10.1016/j.tem.2017.03.003.", "ArticleIdList": ["10.1016/j.tem.2017.03.003", "PMC5477655", "28416361"]}, {"Citation": "Cherrington A.D., Moore M.C., Sindelar D.K., Edgerton D.S. Insulin action on the liver in vivo. Biochem. Soc. Trans. 2007;35:1171\u20131174. doi: 10.1042/BST0351171.", "ArticleIdList": ["10.1042/BST0351171", "17956305"]}, {"Citation": "Edgerton D.S., Lautz M., Scott M., Everett C.A., Stettler K.M., Neal D.W., Chu C.A., Cherrington A.D. Insulin\u2019s direct effects on the liver dominate the control of hepatic glucose production. J. Clin. Investig. 2006;116:521\u2013527. doi: 10.1172/JCI27073.", "ArticleIdList": ["10.1172/JCI27073", "PMC1359060", "16453026"]}, {"Citation": "Meshkani R., Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 2009;42:1331\u20131346. doi: 10.1016/j.clinbiochem.2009.05.018.", "ArticleIdList": ["10.1016/j.clinbiochem.2009.05.018", "19501581"]}, {"Citation": "Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. J. Hepatol. 2007;47:142\u2013156. doi: 10.1016/j.jhep.2007.04.002.", "ArticleIdList": ["10.1016/j.jhep.2007.04.002", "17512085"]}, {"Citation": "Gastaldelli A., Gaggini M., DeFronzo R.A. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study. Diabetes. 2017;66:815\u2013822. doi: 10.2337/db16-1167.", "ArticleIdList": ["10.2337/db16-1167", "28052966"]}, {"Citation": "Czech M.P. Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Mol. Metab. 2020;34:27\u201342. doi: 10.1016/j.molmet.2019.12.014.", "ArticleIdList": ["10.1016/j.molmet.2019.12.014", "PMC6997501", "32180558"]}, {"Citation": "Coelho M., Oliveira T., Fernandes R. Biochemistry of adipose tissue: An endocrine organ. Arch. Med. Sci. 2013;9:191\u2013200. doi: 10.5114/aoms.2013.33181.", "ArticleIdList": ["10.5114/aoms.2013.33181", "PMC3648822", "23671428"]}, {"Citation": "Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847\u2013853. doi: 10.1038/nature05483.", "ArticleIdList": ["10.1038/nature05483", "PMC3212857", "17167472"]}, {"Citation": "Scherer P.E. The many secret lives of adipocytes: Implications for diabetes. Diabetologia. 2019;62:223\u2013232. doi: 10.1007/s00125-018-4777-x.", "ArticleIdList": ["10.1007/s00125-018-4777-x", "PMC6324990", "30465066"]}, {"Citation": "Roden M., Shulman G.I. The integrative biology of type 2 diabetes. Nature. 2019;576:51\u201360. doi: 10.1038/s41586-019-1797-8.", "ArticleIdList": ["10.1038/s41586-019-1797-8", "31802013"]}, {"Citation": "Maki K.C., Kelley K.M., Lawless A.L., Hubacher R.L., Schild A.L., Dicklin M.R., Rains T.M. Validation of insulin sensitivity and secretion indices derived from the liquid meal tolerance test. Diabetes Technol. Ther. 2011;13:661\u2013666. doi: 10.1089/dia.2010.0240.", "ArticleIdList": ["10.1089/dia.2010.0240", "21457067"]}, {"Citation": "Meier J.J., Nauck M.A. Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes. 2010;59:1117\u20131125. doi: 10.2337/db09-1899.", "ArticleIdList": ["10.2337/db09-1899", "PMC2857890", "20427697"]}, {"Citation": "Surampudi P.N., John-Kalarickal J., Fonseca V.A. Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt. Sinai. J. Med. 2009;76:216\u2013226. doi: 10.1002/msj.20113.", "ArticleIdList": ["10.1002/msj.20113", "19421965"]}, {"Citation": "Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131\u20132157. doi: 10.1053/j.gastro.2007.03.054.", "ArticleIdList": ["10.1053/j.gastro.2007.03.054", "17498508"]}, {"Citation": "Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., Peters A.L., Tsapas A., Wender R., Matthews D.R. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140\u2013149. doi: 10.2337/dc14-2441.", "ArticleIdList": ["10.2337/dc14-2441", "25538310"]}, {"Citation": "Nauck M.A., Homberger E., Siegel E.G., Allen R.C., Eaton R.P., Ebert R., Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J. Clin. Endocrinol. Metab. 1986;63:492\u2013498. doi: 10.1210/jcem-63-2-492.", "ArticleIdList": ["10.1210/jcem-63-2-492", "3522621"]}, {"Citation": "Nauck M., St\u00f6ckmann F., Ebert R., Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:46\u201352. doi: 10.1007/BF02427280.", "ArticleIdList": ["10.1007/BF02427280", "3514343"]}, {"Citation": "Drucker D.J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care. 2003;26:2929\u20132940. doi: 10.2337/diacare.26.10.2929.", "ArticleIdList": ["10.2337/diacare.26.10.2929", "14514604"]}, {"Citation": "Drucker D.J. Glucagon-like peptide-1 and the islet beta-cell: Augmentation of cell proliferation and inhibition of apoptosis. Endocrinology. 2003;144:5145\u20135148. doi: 10.1210/en.2003-1147.", "ArticleIdList": ["10.1210/en.2003-1147", "14645210"]}, {"Citation": "Buteau J. GLP-1 receptor signaling: Effects on pancreatic beta-cell proliferation and survival. Diabetes Metab. 2008;34((Suppl. 2)):S73\u2013S77. doi: 10.1016/S1262-3636(08)73398-6.", "ArticleIdList": ["10.1016/S1262-3636(08)73398-6", "18640589"]}, {"Citation": "Gautier J.F., Fetita S., Sobngwi E., Salaun-Martin C. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab. 2005;31:233\u2013242. doi: 10.1016/S1262-3636(07)70190-8.", "ArticleIdList": ["10.1016/S1262-3636(07)70190-8", "16142014"]}, {"Citation": "Irwin N., Hunter K., Frizzell N., Flatt P.R. Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice. Regul. Pept. 2009;153:70\u201376. doi: 10.1016/j.regpep.2008.11.007.", "ArticleIdList": ["10.1016/j.regpep.2008.11.007", "19073224"]}, {"Citation": "Cao L., Li D., Feng P., Li L., Xue G.F., Li G., Holscher C. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson\u2019s disease by reducing chronic inflammation in the brain. Neuroreport. 2016;27:384\u2013391. doi: 10.1097/WNR.0000000000000548.", "ArticleIdList": ["10.1097/WNR.0000000000000548", "26918675"]}, {"Citation": "Boer G.A., Holst J.J. Incretin Hormones and Type 2 Diabetes\u2014Mechanistic Insights and Therapeutic Approaches. Biology. 2020;9:473. doi: 10.3390/biology9120473.", "ArticleIdList": ["10.3390/biology9120473", "PMC7766765", "33339298"]}, {"Citation": "Toft-Nielsen M.B., Damholt M.B., Madsbad S., Hilsted L.M., Hughes T.E., Michelsen B.K., Holst J.J. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 2001;86:3717\u20133723. doi: 10.1210/jcem.86.8.7750.", "ArticleIdList": ["10.1210/jcem.86.8.7750", "11502801"]}, {"Citation": "Faerch K., Vaag A., Holst J.J., Gl\u00fcmer C., Pedersen O., Borch-Johnsen K. Impaired fasting glycaemia vs impaired glucose tolerance: Similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia. 2008;51:853\u2013861. doi: 10.1007/s00125-008-0951-x.", "ArticleIdList": ["10.1007/s00125-008-0951-x", "18317726"]}, {"Citation": "Nauck M.A., Meier J.J. The incretin effect in healthy individuals and those with type 2 diabetes: Physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol. 2016;4:525\u2013536. doi: 10.1016/S2213-8587(15)00482-9.", "ArticleIdList": ["10.1016/S2213-8587(15)00482-9", "26876794"]}, {"Citation": "Lynn F.C., Thompson S.A., Pospisilik J.A., Ehses J.A., Hinke S.A., Pamir N., McIntosh C.H., Pederson R.A. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2003;17:91\u201393.", "ArticleIdList": ["12475913"]}, {"Citation": "Lynn F.C., Pamir N., Ng E.H., McIntosh C.H., Kieffer T.J., Pederson R.A. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes. 2001;50:1004\u20131011. doi: 10.2337/diabetes.50.5.1004.", "ArticleIdList": ["10.2337/diabetes.50.5.1004", "11334402"]}, {"Citation": "Balakumar P., Maung U.K., Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol. Res. 2016;113:600\u2013609. doi: 10.1016/j.phrs.2016.09.040.", "ArticleIdList": ["10.1016/j.phrs.2016.09.040", "27697647"]}, {"Citation": "Von Ah Morano A.E., Dorneles G.P., Peres A., Lira F.S. The role of glucose homeostasis on immune function in response to exercise: The impact of low or higher energetic conditions. J. Cell Physiol. 2020;235:3169\u20133188. doi: 10.1002/jcp.29228.", "ArticleIdList": ["10.1002/jcp.29228", "31565806"]}, {"Citation": "Deed G., Barlow J., Kawol D., Kilov G., Sharma A., Hwa L.Y. Diet and diabetes. Aust. Fam. Phys. 2015;44:192\u2013196.", "ArticleIdList": ["26042397"]}, {"Citation": "Tuso P. Prediabetes and lifestyle modification: Time to prevent a preventable disease. Perm. J. 2014;18:88\u201393. doi: 10.7812/TPP/14-002.", "ArticleIdList": ["10.7812/TPP/14-002", "PMC4116271", "25102521"]}, {"Citation": "Thent Z.C., Das S., Henry L.J. Role of Exercise in the Management of Diabetes Mellitus: The Global Scenario. PLoS ONE. 2013;8:e80436.", "ArticleIdList": ["PMC3827454", "24236181"]}, {"Citation": "Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393\u2013403.", "ArticleIdList": ["PMC1370926", "11832527"]}, {"Citation": "Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., Hu Z.X., Lin J., Xiao J.Z., Cao H.B., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537\u2013544. doi: 10.2337/diacare.20.4.537.", "ArticleIdList": ["10.2337/diacare.20.4.537", "9096977"]}, {"Citation": "Olokoba A.B., Obateru O.A., Olokoba L.B. Type 2 Diabetes Mellitus: A Review of Current Trends. Oman. Med. J. 2012;27:269\u2013273. doi: 10.5001/omj.2012.68.", "ArticleIdList": ["10.5001/omj.2012.68", "PMC3464757", "23071876"]}, {"Citation": "Tran L., Zielinski A., Roach A.H., Jende J.A., Householder A.M., Cole E.E., Atway S.A., Amornyard M., Accursi M.L., Shieh S.W., et al. Pharmacologic treatment of type 2 diabetes: Oral medications. Ann. Pharmacother. 2015;49:540\u2013556. doi: 10.1177/1060028014558289.", "ArticleIdList": ["10.1177/1060028014558289", "25667196"]}, {"Citation": "Song R. Mechanism of Metformin: A Tale of Two Sites. Diabetes Care. 2016;39:187\u2013189. doi: 10.2337/dci15-0013.", "ArticleIdList": ["10.2337/dci15-0013", "26798149"]}, {"Citation": "Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727\u2013735. doi: 10.1136/gutjnl-2012-303839.", "ArticleIdList": ["10.1136/gutjnl-2012-303839", "23804561"]}, {"Citation": "Wen S., Wang C., Gong M., Zhou L. An overview of energy and metabolic regulation. Sci. China. Life Sci. 2019;62:771\u2013790. doi: 10.1007/s11427-018-9371-4.", "ArticleIdList": ["10.1007/s11427-018-9371-4", "30367342"]}, {"Citation": "Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: An overview. Clin. Sci. (Lond.) 2012;122:253\u2013270. doi: 10.1042/CS20110386.", "ArticleIdList": ["10.1042/CS20110386", "PMC3398862", "22117616"]}, {"Citation": "Proks P., Reimann F., Green N., Gribble F., Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 2002;51((Suppl. 3)):S368\u2013S376. doi: 10.2337/diabetes.51.2007.S368.", "ArticleIdList": ["10.2337/diabetes.51.2007.S368", "12475777"]}, {"Citation": "Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008;359:1577\u20131589. doi: 10.1056/NEJMoa0806470.", "ArticleIdList": ["10.1056/NEJMoa0806470", "18784090"]}, {"Citation": "Becker M., Galler A., Raile K. Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3) Pediatrics. 2014;133:e775\u2013e779. doi: 10.1542/peds.2012-2537.", "ArticleIdList": ["10.1542/peds.2012-2537", "24567025"]}, {"Citation": "Skliros N.P., Vlachopoulos C., Tousoulis D. Treatment of diabetes: Crossing to the other side. Hell. J. Cardiol. HJC Hell. Kardiol. Ep. 2016;57:304\u2013310. doi: 10.1016/j.hjc.2016.07.002.", "ArticleIdList": ["10.1016/j.hjc.2016.07.002", "27687958"]}, {"Citation": "Jung Y., Cao Y., Paudel S., Yoon G., Cheon S.H., Bae G.U., Jin L.T., Kim Y.K., Kim S.N. Antidiabetic effect of SN158 through PPARalpha/gamma dual activation in ob/ob mice. Chem.-Biol. Interact. 2017;268:24\u201330. doi: 10.1016/j.cbi.2017.02.014.", "ArticleIdList": ["10.1016/j.cbi.2017.02.014", "28242381"]}, {"Citation": "Gopal S.S., Lakshmi M.J., Sharavana G., Sathaiah G., Sreerama Y.N., Baskaran V. Lactucaxanthin-a potential anti-diabetic carotenoid from lettuce (Lactuca sativa) inhibits alpha-amylase and alpha-glucosidase activity in vitro and in diabetic rats. Food Funct. 2017;8:1124\u20131131. doi: 10.1039/C6FO01655C.", "ArticleIdList": ["10.1039/C6FO01655C", "28170007"]}, {"Citation": "Ishii H., Hayashino Y., Akai Y., Yabuta M., Tsujii S. Dipeptidyl peptidase-4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12-week, open label, randomized controlled study in Japan. J. Diabetes Investig. 2017;9:137\u2013145. doi: 10.1111/jdi.12659.", "ArticleIdList": ["10.1111/jdi.12659", "PMC5754532", "28296349"]}, {"Citation": "Kobayashi K., Yokoh H., Sato Y., Takemoto M., Uchida D., Kanatsuka A., Kuribayashi N., Terano T., Hashimoto N., Sakurai K., et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): A multicenter, randomized, open-label, non-inferiority trial. Diabetes Obes. Metab. 2014;16:761\u2013765.", "ArticleIdList": ["24447683"]}, {"Citation": "Deacon C.F., Mannucci E., Ahren B. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes. Metab. 2012;14:762\u2013767. doi: 10.1111/j.1463-1326.2012.01603.x.", "ArticleIdList": ["10.1111/j.1463-1326.2012.01603.x", "22471248"]}, {"Citation": "Zhou M., Mok M.T., Sun H., Chan A.W., Huang Y., Cheng A.S., Xu G. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. Oncogene. 2017;36:4135\u20134149. doi: 10.1038/onc.2017.38.", "ArticleIdList": ["10.1038/onc.2017.38", "28319060"]}, {"Citation": "Liu J., Hu Y., Zhang H., Xu Y., Wang G. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes. J. Diabetes Its Complicat. 2016;30:1555\u20131559. doi: 10.1016/j.jdiacomp.2016.07.020.", "ArticleIdList": ["10.1016/j.jdiacomp.2016.07.020", "27503404"]}, {"Citation": "Seino Y., Fukushima M., Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J. Diabetes Investig. 2010;1:8\u201323. doi: 10.1111/j.2040-1124.2010.00022.x.", "ArticleIdList": ["10.1111/j.2040-1124.2010.00022.x", "PMC4020673", "24843404"]}, {"Citation": "Ojha A., Ojha U., Mohammed R., Chandrashekar A., Ojha H. Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus. Clin. Pharmacol. 2019;11:57\u201365. doi: 10.2147/CPAA.S202614.", "ArticleIdList": ["10.2147/CPAA.S202614", "PMC6515536", "31191043"]}, {"Citation": "Adeghate E., Mohsin S., Adi F., Ahmed F., Yahya A., Kal\u00e1sz H., Tekes K., Adeghate E.A. An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials. Expert Opin. Investig. Drugs. 2019;28:811\u2013820. doi: 10.1080/13543784.2019.1655539.", "ArticleIdList": ["10.1080/13543784.2019.1655539", "31402716"]}, {"Citation": "Steen O., Goldenberg R.M. The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes. Can. J. Diabetes. 2017;41:517\u2013523. doi: 10.1016/j.jcjd.2017.08.241.", "ArticleIdList": ["10.1016/j.jcjd.2017.08.241", "28942789"]}, {"Citation": "Nauck M.A. Update on developments with SGLT2 inhibitors in the management of type 2 diabetes. Drug Des. Dev. Ther. 2014;8:1335\u20131380. doi: 10.2147/DDDT.S50773.", "ArticleIdList": ["10.2147/DDDT.S50773", "PMC4166348", "25246775"]}, {"Citation": "Kosiborod M., Gause-Nilsson I., Xu J., Sonesson C., Johnsson E. Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure. J. Diabetes Its Complicat. 2017;31:1215\u20131221. doi: 10.1016/j.jdiacomp.2017.02.001.", "ArticleIdList": ["10.1016/j.jdiacomp.2017.02.001", "28284707"]}, {"Citation": "Bailey C.J., Gross J.L., Hennicken D., Iqbal N., Mansfield T.A., List J.F. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: A randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. doi: 10.1186/1741-7015-11-43.", "ArticleIdList": ["10.1186/1741-7015-11-43", "PMC3606470", "23425012"]}, {"Citation": "Brahmkshatriya P.P., Brahmkshatriya P.S. Terpenes: Chemistry, Biological Role, and Therapeutic Applications. In: Ramawat K.G., M\u00e9rillon J.-M., editors. Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes. Springer; Berlin/Heidelberg, Germany: 2013. pp. 2665\u20132691."}, {"Citation": "Tan X.C., Chua K.H., Ravishankar Ram M., Kuppusamy U.R. Monoterpenes: Novel insights into their biological effects and roles on glucose uptake and lipid metabolism in 3T3-L1 adipocytes. Food Chem. 2016;196:242\u2013250. doi: 10.1016/j.foodchem.2015.09.042.", "ArticleIdList": ["10.1016/j.foodchem.2015.09.042", "26593489"]}, {"Citation": "Guimar\u00e3es A.C., Meireles L.M., Lemos M.F., Guimar\u00e3es M.C.C., Endringer D.C., Fronza M., Scherer R. Antibacterial Activity of Terpenes and Terpenoids Present in Essential Oils. Molecules. 2019;24:2471. doi: 10.3390/molecules24132471.", "ArticleIdList": ["10.3390/molecules24132471", "PMC6651100", "31284397"]}, {"Citation": "Kozio\u0142 A., Stryjewska A., Librowski T., Sa\u0142at K., Gawe\u0142 M., Moniczewski A., Lochy\u0144ski S. An overview of the pharmacological properties and potential applications of natural monoterpenes. Mini. Rev. Med. Chem. 2014;14:1156\u20131168. doi: 10.2174/1389557514666141127145820.", "ArticleIdList": ["10.2174/1389557514666141127145820", "25429661"]}, {"Citation": "Ke J., Zhu C., Zhang Y., Zhang W. Anti-Arrhythmic Effects of Linalool via Cx43 Expression in a Rat Model of Myocardial Infarction. Front. Pharmacol. 2020;11:926. doi: 10.3389/fphar.2020.00926.", "ArticleIdList": ["10.3389/fphar.2020.00926", "PMC7329979", "32670059"]}, {"Citation": "Pripdeevech P., Machan T. Fingerprint of volatile flavour constituents and antioxidant activities of teas from Thailand. Food Chem. 2011;125:797\u2013802. doi: 10.1016/j.foodchem.2010.09.074.", "ArticleIdList": ["10.1016/j.foodchem.2010.09.074"]}, {"Citation": "Sajid M., Khan M.R., Ismail H., Latif S., Rahim A.A., Mehboob R., Shah S.A. Antidiabetic and antioxidant potential of Alnus nitida leaves in alloxan induced diabetic rats. J. Ethnopharmacol. 2020;251:112544. doi: 10.1016/j.jep.2020.112544.", "ArticleIdList": ["10.1016/j.jep.2020.112544", "31904496"]}, {"Citation": "Peana A.T., D\u2019Aquila P.S., Panin F., Serra G., Pippia P., Moretti M.D. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomed. Int. J. Phytother. Phytopharm. 2002;9:721\u2013726. doi: 10.1078/094471102321621322.", "ArticleIdList": ["10.1078/094471102321621322", "12587692"]}, {"Citation": "More T., Kulkarni B., Nalawade M., Arvindekar A. Antidiabetic activity of linalool and limonene in streptozotocin-induced diabetic rat: A combinatorial therapy approach. Int. J. Pharm. Pharm. Sci. 2014;6:159\u2013163."}, {"Citation": "Garba H.A., Mohammed A., Ibrahim M.A., Shuaibu M.N. Effect of lemongrass (Cymbopogon citratus Stapf) tea in a type 2 diabetes rat model. Clin. Phytosci. 2020;6:19. doi: 10.1186/s40816-020-00167-y.", "ArticleIdList": ["10.1186/s40816-020-00167-y"]}, {"Citation": "Kwon Y.I., Apostolidis E., Shetty K. Evaluation of pepper (Capsicum annuum) for management of diabetes and hypertension. J. Food Biochem. 2007;31:370\u2013385. doi: 10.1111/j.1745-4514.2007.00120.x.", "ArticleIdList": ["10.1111/j.1745-4514.2007.00120.x"]}, {"Citation": "Boaduo N.K., Katerere D., Eloff J.N., Naidoo V. Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods. Pharm. Biol. 2014;52:756\u2013761. doi: 10.3109/13880209.2013.869828.", "ArticleIdList": ["10.3109/13880209.2013.869828", "24559378"]}, {"Citation": "Jumepaeng T., Prachakool S., Luthria D.L., Chanthai S. Determination of antioxidant capacity and \u03b1-amylase inhibitory activity of the essential oils from citronella grass and lemongrass. Int. Food Res. J. 2013;20:481\u2013485."}, {"Citation": "Deepa B., Venkataraman A. Linalool, a plant derived monoterpene alcohol, rescues kidney from diabetes-induced nephropathic changes via blood glucose reduction. Diabetol. Croat. 2011;40:121\u2013137."}, {"Citation": "Shah G., Shri R., Panchal V., Sharma N., Singh B., Mann A.S. Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass) J. Adv. Pharm. Technol. Res. 2011;2:3\u20138. doi: 10.4103/2231-4040.79796.", "ArticleIdList": ["10.4103/2231-4040.79796", "PMC3217679", "22171285"]}, {"Citation": "Najafian M., Ebrahim-Habibi A., Yaghmaei P., Parivar K., Larijani B. Citral as a potential antihyperlipidemic medicine in diabetes: A study on streptozotocin-induced diabetic rats. Iran. J. Diabetes Lipid Disord. 2011;10:3."}, {"Citation": "Molinaro A., Wahlstr\u00f6m A., Marschall H.U. Role of Bile Acids in Metabolic Control. Trends Endocrinol. Metab. 2018;29:31\u201341. doi: 10.1016/j.tem.2017.11.002.", "ArticleIdList": ["10.1016/j.tem.2017.11.002", "29195686"]}, {"Citation": "Schaap F.G., Trauner M., Jansen P.L. Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 2014;11:55\u201367. doi: 10.1038/nrgastro.2013.151.", "ArticleIdList": ["10.1038/nrgastro.2013.151", "23982684"]}, {"Citation": "Ooi C.P., Loke S.C. Colesevelam for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2012;12:Cd009361. doi: 10.1002/14651858.CD009361.pub2.", "ArticleIdList": ["10.1002/14651858.CD009361.pub2", "PMC6486226", "23235674"]}, {"Citation": "Zieve F.J., Kalin M.F., Schwartz S.L., Jones M.R., Bailey W.L. Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin. Ther. 2007;29:74\u201383. doi: 10.1016/j.clinthera.2007.01.003.", "ArticleIdList": ["10.1016/j.clinthera.2007.01.003", "17379048"]}, {"Citation": "Damci T., Tatliagac S., Osar Z., Ilkova H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur. J. Intern. Med. 2003;14:357\u2013360. doi: 10.1016/S0953-6205(03)90001-X.", "ArticleIdList": ["10.1016/S0953-6205(03)90001-X", "14769493"]}, {"Citation": "Nozue T., Michishita I., Mizuguchi I. Effects of ezetimibe on glucose metabolism in patients with type 2 diabetes: A 12-week, open-label, uncontrolled, pilot study. Curr. Ther. Res. Clin. Exp. 2010;71:252\u2013258. doi: 10.1016/j.curtheres.2010.08.002.", "ArticleIdList": ["10.1016/j.curtheres.2010.08.002", "PMC3969592", "24688147"]}, {"Citation": "Modak T., Mukhopadhaya A. Effects of citral, a naturally occurring antiadipogenic molecule, on an energy-intense diet model of obesity. Indian J. Pharmacol. 2011;43:300\u2013305. doi: 10.4103/0253-7613.81515.", "ArticleIdList": ["10.4103/0253-7613.81515", "PMC3113383", "21713095"]}, {"Citation": "Mishra C., Khalid M.A., Fatima N., Singh B., Tripathi D., Waseem M., Mahdi A.A. Effects of citral on oxidative stress and hepatic key enzymes of glucose metabolism in streptozotocin/high-fat-diet induced diabetic dyslipidemic rats. Iran. J. Basic Med. Sci. 2019;22:49\u201357.", "ArticleIdList": ["PMC6437455", "30944708"]}, {"Citation": "Lei Y., Fu P., Jun X., Cheng P. Pharmacological Properties of Geraniol-A Review. Planta Med. 2019;85:48\u201355. doi: 10.1055/a-0750-6907.", "ArticleIdList": ["10.1055/a-0750-6907", "30308694"]}, {"Citation": "Babukumar S., Vinothkumar V., Sankaranarayanan C., Srinivasan S. Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm. Biol. 2017;55:1442\u20131449. doi: 10.1080/13880209.2017.1301494.", "ArticleIdList": ["10.1080/13880209.2017.1301494", "PMC6130491", "28330423"]}, {"Citation": "Kamble S.P., Ghadyale V.A., Patil R.S., Haldavnekar V.S., Arvindekar A.U. Inhibition of GLUT2 transporter by geraniol from Cymbopogon martinii: A novel treatment for diabetes mellitus in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 2020;72:294\u2013304. doi: 10.1111/jphp.13194.", "ArticleIdList": ["10.1111/jphp.13194", "31737917"]}, {"Citation": "Srinivasan S., Muruganathan U. Antidiabetic efficacy of citronellol, a citrus monoterpene by ameliorating the hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Chem.-Biol. Interact. 2016;250:38\u201346. doi: 10.1016/j.cbi.2016.02.020.", "ArticleIdList": ["10.1016/j.cbi.2016.02.020", "26944432"]}, {"Citation": "De Toledo L.G., Ramos M.A., Sp\u00f3sito L., Castilho E.M., Pavan F.R., Lopes \u00c9de O., Zocolo G.J., Silva F.A., Soares T.H., Dos Santos A.G., et al. Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species. Int. J. Mol. Sci. 2016;17:1252. doi: 10.3390/ijms17081252.", "ArticleIdList": ["10.3390/ijms17081252", "PMC5000650", "27517903"]}, {"Citation": "Abena A.A., Gbenou J.D., Yayi E., Moudachirou M., Ongoka R.P., Ouamba J.M., Silou T. Comparative chemical and analgesic properties of essential oils of Cymbopogon nardus (L) Rendle of Benin and Congo. Afr. J. Tradit. Complement. Altern. Med. 2007;4:267\u2013272. doi: 10.4314/ajtcam.v4i3.31218.", "ArticleIdList": ["10.4314/ajtcam.v4i3.31218", "PMC2816489", "20161888"]}, {"Citation": "Boukhris M., Bouaziz M., Feki I., Jemai H., El Feki A., Sayadi S. Hypoglycemic and antioxidant effects of leaf essential oil of Pelargonium graveolens L\u2019H\u00e9r. in alloxan induced diabetic rats. Lipids Health Dis. 2012;11:81. doi: 10.1186/1476-511X-11-81.", "ArticleIdList": ["10.1186/1476-511X-11-81", "PMC3439344", "22734822"]}, {"Citation": "Santos M., Moreira F., Fraga B., Sousa D., Bonjardim L., Quintans-J\u00fanior L. Cardiovascular effects of monoterpenes: A review. Rev. Bras. Farmacogn. 2011;21:764\u2013771. doi: 10.1590/S0102-695X2011005000119.", "ArticleIdList": ["10.1590/S0102-695X2011005000119"]}, {"Citation": "Buchbauer G., Jirovetz L., J\u00e4ger W., Dietrich H., Plank C. Aromatherapy: Evidence for sedative effects of the essential oil of lavender after inhalation. Z. F\u00fcr Nat. C. 1991;46:1067\u20131072. doi: 10.1515/znc-1991-11-1223.", "ArticleIdList": ["10.1515/znc-1991-11-1223", "1817516"]}, {"Citation": "Dzumayev K., Tsibulskaya I., Zenkevich I., Tkachenko K., Satzyperova I. Essential Oils of Salvia sclarea L. Produced from Plants Grown in Southern Uzbekistan. J. Essent. Oil Res. 1995;7:597\u2013604. doi: 10.1080/10412905.1995.9700513.", "ArticleIdList": ["10.1080/10412905.1995.9700513"]}, {"Citation": "Yang H.J., Kim K.Y., Kang P., Lee H.S., Seol G.H. Effects of Salvia sclarea on chronic immobilization stress induced endothelial dysfunction in rats. BMC Complement. Altern. Med. 2014;14:396. doi: 10.1186/1472-6882-14-396.", "ArticleIdList": ["10.1186/1472-6882-14-396", "PMC4200217", "25311097"]}, {"Citation": "Shin Y.K., Hsieh Y.S., Kwon S., Lee H.S., Seol G.H. Linalyl acetate restores endothelial dysfunction and hemodynamic alterations in diabetic rats exposed to chronic immobilization stress. J. Appl. Physiol. (Bethesda Md. 1985) 2018;124:1274\u20131283. doi: 10.1152/japplphysiol.01018.2017.", "ArticleIdList": ["10.1152/japplphysiol.01018.2017", "29470152"]}, {"Citation": "Sun J. D-Limonene: Safety and clinical applications. Altern. Med. Rev. 2007;12:259\u2013264.", "ArticleIdList": ["18072821"]}, {"Citation": "Bacanl\u0131 M., Anlar H.G., Ayd\u0131n S., \u00c7al T., Ar\u0131 N., \u00dcnde\u011fer Bucurgat \u00dc., Ba\u015faran A.A., Ba\u015faran N. D-limonene ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2017;110:434\u2013442. doi: 10.1016/j.fct.2017.09.020.", "ArticleIdList": ["10.1016/j.fct.2017.09.020", "28923438"]}, {"Citation": "Joglekar M.M., Panaskar S.N., Chougale A.D., Kulkarni M.J., Arvindekar A.U. A novel mechanism for antiglycative action of limonene through stabilization of protein conformation. Mol. Biosyst. 2013;9:2463\u20132472. doi: 10.1039/c3mb00020f.", "ArticleIdList": ["10.1039/c3mb00020f", "23872839"]}, {"Citation": "Murali R., Saravanan R. Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed. Prev. Nutr. 2012;2:269\u2013275. doi: 10.1016/j.bionut.2012.08.008.", "ArticleIdList": ["10.1016/j.bionut.2012.08.008"]}, {"Citation": "Bossou A.D., Mangelinckx S., Yedomonhan H., Boko P.M., Akogbeto M.C., De Kimpe N., Avlessi F., Sohounhloue D.C. Chemical composition and insecticidal activity of plant essential oils from Benin against Anopheles gambiae (Giles) Parasit Vectors. 2013;6:337. doi: 10.1186/1756-3305-6-337.", "ArticleIdList": ["10.1186/1756-3305-6-337", "PMC3866997", "24298981"]}, {"Citation": "Liu P., Liu X.C., Dong H.W., Liu Z.L., Du S.S., Deng Z.W. Chemical composition and insecticidal activity of the essential oil of Illicium pachyphyllum fruits against two grain storage insects. Molecules. 2012;17:14870\u201314881. doi: 10.3390/molecules171214870.", "ArticleIdList": ["10.3390/molecules171214870", "PMC6268823", "23519259"]}, {"Citation": "Fang R., Jiang C.H., Wang X.Y., Zhang H.M., Liu Z.L., Zhou L., Du S.S., Deng Z.W. Insecticidal activity of essential oil of Carum Carvi fruits from China and its main components against two grain storage insects. Molecules. 2010;15:9391\u20139402. doi: 10.3390/molecules15129391.", "ArticleIdList": ["10.3390/molecules15129391", "PMC6259201", "21173724"]}, {"Citation": "Bhatia S.P., McGinty D., Letizia C.S., Api A.M. Fragrance material review on carveol. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2008;46((Suppl. 11)):S85\u2013S87. doi: 10.1016/j.fct.2008.06.032.", "ArticleIdList": ["10.1016/j.fct.2008.06.032", "18640224"]}, {"Citation": "Wagner K.H., Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann. Nutr. Metab. 2003;47:95\u2013106. doi: 10.1159/000070030.", "ArticleIdList": ["10.1159/000070030", "12743459"]}, {"Citation": "Marques F.M., Figueira M.M., Schmitt E.F.P., Kondratyuk T.P., Endringer D.C., Scherer R., Fronza M. In vitro anti-inflammatory activity of terpenes via suppression of superoxide and nitric oxide generation and the NF-\u03baB signalling pathway. Inflammopharmacology. 2019;27:281\u2013289. doi: 10.1007/s10787-018-0483-z.", "ArticleIdList": ["10.1007/s10787-018-0483-z", "29675712"]}, {"Citation": "Rossi Y.E., Palacios S.M. Fumigant toxicity of Citrus sinensis essential oil on Musca domestica L. adults in the absence and presence of a P450 inhibitor. Acta Trop. 2013;127:33\u201337. doi: 10.1016/j.actatropica.2013.03.009.", "ArticleIdList": ["10.1016/j.actatropica.2013.03.009", "23545130"]}, {"Citation": "Sales A., Felipe L., Bicas J. Production, Properties, and Applications of \u03b1-Terpineol. Food Bioprocess Technol. 2020;13:1261\u20131279. doi: 10.1007/s11947-020-02461-6.", "ArticleIdList": ["10.1007/s11947-020-02461-6"]}, {"Citation": "Capetti F., Cagliero C., Marengo A., Bicchi C., Rubiolo P., Sgorbini B. Bio-Guided Fractionation Driven by In Vitro \u03b1-Amylase Inhibition Assays of Essential Oils Bearing Specialized Metabolites with Potential Hypoglycemic Activity. Plants. 2020;9:1242. doi: 10.3390/plants9091242.", "ArticleIdList": ["10.3390/plants9091242", "PMC7569863", "32967115"]}, {"Citation": "Sousa G.M., Cazarin C.B.B., Mar\u00f3stica Junior M.R., Lamas C.A., Quitete V., Pastore G.M., Bicas J.L. The effect of \u03b1-terpineol enantiomers on biomarkers of rats fed a high-fat diet. Heliyon. 2020;6:e03752. doi: 10.1016/j.heliyon.2020.e03752.", "ArticleIdList": ["10.1016/j.heliyon.2020.e03752", "PMC7199010", "32382672"]}, {"Citation": "Bouyahya A., Chamkhi I., Guaouguaou F.E., Benali T., Balahbib A., El Omari N., Taha D., El-Shazly M., El Menyiy N. Ethnomedicinal use, phytochemistry, pharmacology, and food benefits of Thymus capitatus. J. Ethnopharmacol. 2020;259:112925. doi: 10.1016/j.jep.2020.112925.", "ArticleIdList": ["10.1016/j.jep.2020.112925", "32423878"]}, {"Citation": "Abbasi S., Gharaghani S., Benvidi A., Rezaeinasab M. New insights into the efficiency of thymol synergistic effect with p-cymene in inhibiting advanced glycation end products: A multi-way analysis based on spectroscopic and electrochemical methods in combination with molecular docking study. J. Pharm. Biomed. Anal. 2018;150:436\u2013451. doi: 10.1016/j.jpba.2017.12.042.", "ArticleIdList": ["10.1016/j.jpba.2017.12.042", "29291586"]}, {"Citation": "Miladi H., Zmantar T., Kouidhi B., Chaabouni Y., Mahdouani K., Bakhrouf A., Chaieb K. Use of carvacrol, thymol, and eugenol for biofilm eradication and resistance modifying susceptibility of Salmonella enterica serovar Typhimurium strains to nalidixic acid. Microb. Pathog. 2017;104:56\u201363. doi: 10.1016/j.micpath.2017.01.012.", "ArticleIdList": ["10.1016/j.micpath.2017.01.012", "28062292"]}, {"Citation": "Veras H.N., Araruna M.K., Costa J.G., Coutinho H.D., Kerntopf M.R., Botelho M.A., Menezes I.R. Topical antiinflammatory activity of essential oil of Lippia sidoides cham: Possible mechanism of action. Phytother. Res. PTR. 2013;27:179\u2013185. doi: 10.1002/ptr.4695.", "ArticleIdList": ["10.1002/ptr.4695", "22511564"]}, {"Citation": "Kang S.H., Kim Y.S., Kim E.K., Hwang J.W., Jeong J.H., Dong X., Lee J.W., Moon S.H., Jeon B.T., Park P.J. Anticancer Effect of Thymol on AGS Human Gastric Carcinoma Cells. J. Microbiol. Biotechnol. 2016;26:28\u201337. doi: 10.4014/jmb.1506.06073.", "ArticleIdList": ["10.4014/jmb.1506.06073", "26437948"]}, {"Citation": "Haque M.R., Ansari S.H., Najmi A.K., Ahmad M.A. Monoterpene phenolic compound thymol prevents high fat diet induced obesity in murine model. Toxicol. Mech. Methods. 2014;24:116\u2013123. doi: 10.3109/15376516.2013.861888.", "ArticleIdList": ["10.3109/15376516.2013.861888", "24175857"]}, {"Citation": "Fang F., Li H., Qin T., Li M., Ma S. Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway. Metab. Brain Dis. 2017;32:385\u2013393. doi: 10.1007/s11011-016-9921-z.", "ArticleIdList": ["10.1007/s11011-016-9921-z", "27761760"]}, {"Citation": "Saravanan S., Pari L. Role of thymol on hyperglycemia and hyperlipidemia in high fat diet-induced type 2 diabetic C57BL/6J mice. Eur. J. Pharmacol. 2015;761:279\u2013287. doi: 10.1016/j.ejphar.2015.05.034.", "ArticleIdList": ["10.1016/j.ejphar.2015.05.034", "26007642"]}, {"Citation": "Homocysteine Lowering Trialists Collaboration Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am. J. Clin. Nutr. 2005;82:806\u2013812. doi: 10.1093/ajcn/82.4.806.", "ArticleIdList": ["10.1093/ajcn/82.4.806", "16210710"]}, {"Citation": "Saravanan S., Pari L. Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL/6J mice. Chem.-Biol. Interact. 2016;245:1\u201311. doi: 10.1016/j.cbi.2015.11.033.", "ArticleIdList": ["10.1016/j.cbi.2015.11.033", "26680107"]}, {"Citation": "Oskouei B.G., Abbaspour-Ravasjani S., Jamal Musavinejad S., Ahmad Salehzadeh S., Abdolhosseinzadeh A., Hamishehkar H., Ghahremanzadeh K., Shokouhi B. In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats. Drug Res. 2019;69:46\u201352. doi: 10.1055/a-0646-3803.", "ArticleIdList": ["10.1055/a-0646-3803", "30103218"]}, {"Citation": "Hyun T.K., Kim H.-C., Kim J.-S. Antioxidant and antidiabetic activity of Thymus quinquecostatus Celak. Ind. Crops Prod. 2014;52:611\u2013616. doi: 10.1016/j.indcrop.2013.11.039.", "ArticleIdList": ["10.1016/j.indcrop.2013.11.039"]}, {"Citation": "Behera G.C., Parida K.M., Das D.P. Facile fabrication of aluminum-promoted vanadium phosphate: A highly active heterogeneous catalyst for isopropylation of toluene to cymene. J. Catal. 2012;289:190\u2013198. doi: 10.1016/j.jcat.2012.02.004.", "ArticleIdList": ["10.1016/j.jcat.2012.02.004"]}, {"Citation": "Bonjardim L.R., Cunha E.S., Guimar\u00e3es A.G., Santana M.F., Oliveira M.G., Serafini M.R., Ara\u00fajo A.A., Antoniolli A.R., Cavalcanti S.C., Santos M.R., et al. Evaluation of the anti-inflammatory and antinociceptive properties of p-cymene in mice. Z. F\u00fcr Nat. C. 2012;67:15\u201321. doi: 10.1515/znc-2012-1-203.", "ArticleIdList": ["10.1515/znc-2012-1-203", "22486037"]}, {"Citation": "Nabavi S.M., Marchese A., Izadi M., Curti V., Daglia M., Nabavi S.F. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food Chem. 2015;173:339\u2013347. doi: 10.1016/j.foodchem.2014.10.042.", "ArticleIdList": ["10.1016/j.foodchem.2014.10.042", "25466031"]}, {"Citation": "Nickavar B., Adeli A., Nickavar A. TLC-Bioautography and GC-MS Analyses for Detection and Identification of Antioxidant Constituents of Trachyspermum copticum Essential Oil. Iran. J. Pharm. Res. 2014;13:127\u2013133.", "ArticleIdList": ["PMC3985236", "24734063"]}, {"Citation": "Lotfi P., Yaghmaei P., Ebrahim-Habibi A. Cymene and Metformin treatment effect on biochemical parameters of male NMRI mice fed with high fat diet. J. Diabetes Metab. Disord. 2015;14:52. doi: 10.1186/s40200-015-0182-x.", "ArticleIdList": ["10.1186/s40200-015-0182-x", "PMC4490725", "26146609"]}, {"Citation": "Joglekar M., Panaskar S., Arvindekar A. Inhibition of advanced glycation end product formation by cymene-A common food constituent. J. Funct. Foods. 2013;6:107\u2013115. doi: 10.1016/j.jff.2013.09.024.", "ArticleIdList": ["10.1016/j.jff.2013.09.024"]}, {"Citation": "Oz M., El Nebrisi E.G., Yang K.S., Howarth F.C., Al Kury L.T. Cellular and Molecular Targets of Menthol Actions. Front. Pharmacol. 2017;8:472. doi: 10.3389/fphar.2017.00472.", "ArticleIdList": ["10.3389/fphar.2017.00472", "PMC5513973", "28769802"]}, {"Citation": "Patel T., Ishiuji Y., Yosipovitch G. Menthol: A refreshing look at this ancient compound. J. Am. Acad. Dermatol. 2007;57:873\u2013878. doi: 10.1016/j.jaad.2007.04.008.", "ArticleIdList": ["10.1016/j.jaad.2007.04.008", "17498839"]}, {"Citation": "Muruganathan U., Srinivasan S., Vinothkumar V. Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic \u03b2-cell apoptosis in streptozotocin-nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Biomed. Pharmacother. Biomed. Pharmacother. 2017;92:229\u2013239. doi: 10.1016/j.biopha.2017.05.068.", "ArticleIdList": ["10.1016/j.biopha.2017.05.068", "28549291"]}, {"Citation": "Khare P., Mangal P., Baboota R.K., Jagtap S., Kumar V., Singh D.P., Boparai R.K., Sharma S.S., Khardori R., Bhadada S.K., et al. Involvement of Glucagon in Preventive Effect of Menthol Against High Fat Diet Induced Obesity in Mice. Front. Pharmacol. 2018;9:1244. doi: 10.3389/fphar.2018.01244.", "ArticleIdList": ["10.3389/fphar.2018.01244", "PMC6250823", "30505271"]}, {"Citation": "Ceylan E., \u00d6zbek H., A\u00f0ao\u00f0lu Z. Investigation of The Level of The Median Lethal Dose (LD 50) and The Hypoglycemic Effect of Cuminum cyminum L. Fruit Essential Oil Extract in Healthy and Diabetic Mice. Van T\u0131p. Derg. (Van Med. J.) 2003;10:29\u201335."}, {"Citation": "Pe\u00f1a-Montes D.J., Huerta-Cervantes M., R\u00edos-Silva M., Trujillo X., Huerta M., Noriega-Cisneros R., Salgado-Garciglia R., Saavedra-Molina A. Protective Effect of the Hexanic Extract of Eryngium carlinae Inflorescences In Vitro, in Yeast, and in Streptozotocin-Induced Diabetic Male Rats. Antioxidants. 2019;8:73. doi: 10.3390/antiox8030073.", "ArticleIdList": ["10.3390/antiox8030073", "PMC6466845", "30917540"]}, {"Citation": "Noriega-Cisneros R., Ortiz-\u00c1vila O., Esquivel-Guti\u00e9rrez E., Clemente-Guerrero M., Manzo-Avalos S., Salgado-Garciglia R., Cort\u00e9s-Rojo C., Boldogh I., Saavedra-Molina A. Hypolipidemic Activity of Eryngium carlinae on Streptozotocin-Induced Diabetic Rats. Biochem. Res. Int. 2012;2012:603501. doi: 10.1155/2012/603501.", "ArticleIdList": ["10.1155/2012/603501", "PMC3227232", "22162811"]}, {"Citation": "Nuzzo D., Galizzi G., Amato A., Terzo S., Picone P., Cristaldi L., Mul\u00e8 F., Di Carlo M. Regular Intake of Pistachio Mitigates the Deleterious Effects of a High Fat-Diet in the Brain of Obese Mice. Antioxidants. 2020;9:317. doi: 10.3390/antiox9040317.", "ArticleIdList": ["10.3390/antiox9040317", "PMC7222408", "32326575"]}, {"Citation": "Bagheri S., Sarabi M.M., Khosravi P., Khorramabadi R.M., Veiskarami S., Ahmadvand H., Keshvari M. Effects of Pistacia atlantica on Oxidative Stress Markers and Antioxidant Enzymes Expression in Diabetic Rats. J. Am. Coll. Nutr. 2019;38:267\u2013274. doi: 10.1080/07315724.2018.1482577.", "ArticleIdList": ["10.1080/07315724.2018.1482577", "30716018"]}, {"Citation": "H\u00f6ld K.M., Sirisoma N.S., Ikeda T., Narahashi T., Casida J.E. Alpha-thujone (the active component of absinthe): Gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc. Natl. Acad. Sci. USA. 2000;97:3826\u20133831. doi: 10.1073/pnas.070042397.", "ArticleIdList": ["10.1073/pnas.070042397", "PMC18101", "10725394"]}, {"Citation": "Baddar N.W., Aburjai T.A., Taha M.O., Disi A.M. Thujone corrects cholesterol and triglyceride profiles in diabetic rat model. Nat. Prod. Res. 2011;25:1180\u20131184. doi: 10.1080/14786419.2010.496116.", "ArticleIdList": ["10.1080/14786419.2010.496116", "21740283"]}, {"Citation": "Alkhateeb H., Chabowski A., Glatz J.F., Luiken J.F., Bonen A. Two phases of palmitate-induced insulin resistance in skeletal muscle: Impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am. J. Physiol. Endocrinol. Metab. 2007;293:E783\u2013E793. doi: 10.1152/ajpendo.00685.2006.", "ArticleIdList": ["10.1152/ajpendo.00685.2006", "17550999"]}, {"Citation": "Alkhateeb H., Bonen A. Thujone, a component of medicinal herbs, rescues palmitate-induced insulin resistance in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010;299:R804\u2013R812. doi: 10.1152/ajpregu.00216.2010.", "ArticleIdList": ["10.1152/ajpregu.00216.2010", "20573988"]}, {"Citation": "Lachenmeier D.W., Walch S.G. The choice of thujone as drug for diabetes. Nat. Prod. Res. 2011;25:1890\u20131892. doi: 10.1080/14786419.2011.622279.", "ArticleIdList": ["10.1080/14786419.2011.622279", "21988529"]}, {"Citation": "Lindmark-Henriksson M., Isaksson D., Vanek T., Valterov\u00e1 I., H\u00f6gberg H.E., Sj\u00f6din K. Transformation of terpenes using a Picea abies suspension culture. J. Biotechnol. 2004;107:173\u2013184. doi: 10.1016/j.jbiotec.2003.10.009.", "ArticleIdList": ["10.1016/j.jbiotec.2003.10.009", "14711500"]}, {"Citation": "Vibha J., Choudhary K., Singh M., Rathore M., Shekhawat N. A Study on Pharmacokinetics and Therapeutic Efficacy of Glycyrrhiza glabra: A Miracle Medicinal Herb. Bot. Res. Int. 2009;2:157\u2013163."}, {"Citation": "Ayyasamy R., Leelavinothan P. Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats. Pharm. Biol. 2016;54:2521\u20132527. doi: 10.3109/13880209.2016.1168852.", "ArticleIdList": ["10.3109/13880209.2016.1168852", "27158912"]}, {"Citation": "Rathinam A., Pari L., Chandramohan R., Sheikh B.A. Histopathological findings of the pancreas, liver, and carbohydrate metabolizing enzymes in STZ-induced diabetic rats improved by administration of myrtenal. J. Physiol. Biochem. 2014;70:935\u2013946. doi: 10.1007/s13105-014-0362-z.", "ArticleIdList": ["10.1007/s13105-014-0362-z", "25292424"]}, {"Citation": "Rathinam A., Pari L. Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats. Chem.-Biol. Interact. 2016;256:161\u2013166. doi: 10.1016/j.cbi.2016.07.009.", "ArticleIdList": ["10.1016/j.cbi.2016.07.009", "27417257"]}, {"Citation": "Rathinam A., Pari L., Venkatesan M., Munusamy S. Myrtenal attenuates oxidative stress and inflammation in a rat model of streptozotocin-induced diabetes. Arch. Physiol. Biochem. 2019:1\u20139. doi: 10.1080/13813455.2019.1670212.", "ArticleIdList": ["10.1080/13813455.2019.1670212", "31564173"]}, {"Citation": "Neves G.N., Nogueira G., Vardanega R., Meireles M.A. Identification and quantification of genipin and geniposide from Genipa americana L. by HPLC-DAD using a fused-core column. Food Sci. Technol. 2018;38:116\u2013122. doi: 10.1590/1678-457x.17317.", "ArticleIdList": ["10.1590/1678-457x.17317"]}, {"Citation": "Wang S.C., Liao H.J., Lee W.C., Huang C.M., Tsai T.H. Using orthogonal array to obtain gradient liquid chromatography conditions of enhanced peak intensity to determine geniposide and genipin with electrospray tandem mass spectrometry. J. Chromatogr. A. 2008;1212:68\u201375. doi: 10.1016/j.chroma.2008.10.035.", "ArticleIdList": ["10.1016/j.chroma.2008.10.035", "18962644"]}, {"Citation": "Shanmugam M.K., Shen H., Tang F.R., Arfuso F., Rajesh M., Wang L., Kumar A.P., Bian J., Goh B.C., Bishayee A., et al. Potential role of genipin in cancer therapy. Pharmacol. Res. 2018;133:195\u2013200. doi: 10.1016/j.phrs.2018.05.007.", "ArticleIdList": ["10.1016/j.phrs.2018.05.007", "29758279"]}, {"Citation": "Wang J., Zhang Y., Liu R., Li X., Cui Y., Qu L. Geniposide protects against acute alcohol-induced liver injury in mice via up-regulating the expression of the main antioxidant enzymes. Can. J. Physiol. Pharmacol. 2015;93:261\u2013267. doi: 10.1139/cjpp-2014-0536.", "ArticleIdList": ["10.1139/cjpp-2014-0536", "25730420"]}, {"Citation": "Koo H.J., Lim K.H., Jung H.J., Park E.H. Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. J. Ethnopharmacol. 2006;103:496\u2013500. doi: 10.1016/j.jep.2005.08.011.", "ArticleIdList": ["10.1016/j.jep.2005.08.011", "16169698"]}, {"Citation": "Jiang Y.Q., Chang G.L., Wang Y., Zhang D.Y., Cao L., Liu J. Geniposide Prevents Hypoxia/Reoxygenation-Induced Apoptosis in H9c2 Cells: Improvement of Mitochondrial Dysfunction and Activation of GLP-1R and the PI3K/AKT Signaling Pathway. Cell Physiol. Biochem. 2016;39:407\u2013421. doi: 10.1159/000445634.", "ArticleIdList": ["10.1159/000445634", "27372651"]}, {"Citation": "Ma C.J., Nie A.F., Zhang Z.J., Zhang Z.G., Du L., Li X.Y., Ning G. Genipin stimulates glucose transport in C2C12 myotubes via an IRS-1 and calcium-dependent mechanism. J. Endocrinol. 2013;216:353\u2013362. doi: 10.1530/JOE-11-0473.", "ArticleIdList": ["10.1530/JOE-11-0473", "23257267"]}, {"Citation": "Guan L., Feng H., Gong D., Zhao X., Cai L., Wu Q., Yuan B., Yang M., Zhao J., Zou Y. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. Exp. Gerontol. 2013;48:1387\u20131394. doi: 10.1016/j.exger.2013.09.001.", "ArticleIdList": ["10.1016/j.exger.2013.09.001", "24041487"]}, {"Citation": "Guan L., Gong D., Yang S., Shen N., Zhang S., Li Y., Wu Q., Yuan B., Sun Y., Dai N., et al. Genipin ameliorates diet-induced obesity via promoting lipid mobilization and browning of white adipose tissue in rats. Phytother. Res. PTR. 2018;32:723\u2013732. doi: 10.1002/ptr.6022.", "ArticleIdList": ["10.1002/ptr.6022", "29377296"]}, {"Citation": "Zhong H., Chen K., Feng M., Shao W., Wu J., Liang T., Liu C. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis. Febs J. 2018;285:501\u2013517. doi: 10.1111/febs.14349.", "ArticleIdList": ["10.1111/febs.14349", "29197188"]}, {"Citation": "Kojima K., Shimada T., Nagareda Y., Watanabe M., Ishizaki J., Sai Y., Miyamoto K., Aburada M. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells. Biol. Pharm. Bull. 2011;34:1613\u20131618. doi: 10.1248/bpb.34.1613.", "ArticleIdList": ["10.1248/bpb.34.1613", "21963504"]}, {"Citation": "Liu J., Yin F., Xiao H., Guo L., Gao X. Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced \u03b2-cell apoptosis. Toxicol Vitr. 2012;26:1093\u20131097. doi: 10.1016/j.tiv.2012.07.004.", "ArticleIdList": ["10.1016/j.tiv.2012.07.004", "22819839"]}, {"Citation": "Guo L.X., Liu J.H., Zheng X.X., Yin Z.Y., Kosaraju J., Tam K.Y. Geniposide improves insulin production and reduces apoptosis in high glucose-induced glucotoxic insulinoma cells. Eur. J. Pharm. Sci. 2017;110:70\u201376. doi: 10.1016/j.ejps.2017.03.038.", "ArticleIdList": ["10.1016/j.ejps.2017.03.038", "28363490"]}, {"Citation": "Liu J., Guo L., Yin F., Zhang Y., Liu Z., Wang Y. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells. PLoS ONE. 2013;8:e78315. doi: 10.1371/journal.pone.0078315.", "ArticleIdList": ["10.1371/journal.pone.0078315", "PMC3805567", "24167617"]}, {"Citation": "Zhang Y., Ding Y., Zhong X., Guo Q., Wang H., Gao J., Bai T., Ren L., Guo Y., Jiao X., et al. Geniposide acutely stimulates insulin secretion in pancreatic \u03b2-cells by regulating GLP-1 receptor/cAMP signaling and ion channels. Mol. Cell Endocrinol. 2016;430:89\u201396. doi: 10.1016/j.mce.2016.04.020.", "ArticleIdList": ["10.1016/j.mce.2016.04.020", "27126219"]}, {"Citation": "Hodson D.J., Tarasov A.I., Gimeno Brias S., Mitchell R.K., Johnston N.R., Haghollahi S., Cane M.C., Bugliani M., Marchetti P., Bosco D., et al. Incretin-modulated beta cell energetics in intact islets of Langerhans. Mol. Endocrinol. 2014;28:860\u2013871. doi: 10.1210/me.2014-1038.", "ArticleIdList": ["10.1210/me.2014-1038", "PMC4042069", "24766140"]}, {"Citation": "Jacobson D.A., Kuznetsov A., Lopez J.P., Kash S., Amm\u00e4l\u00e4 C.E., Philipson L.H. Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab. 2007;6:229\u2013235. doi: 10.1016/j.cmet.2007.07.010.", "ArticleIdList": ["10.1016/j.cmet.2007.07.010", "PMC2699758", "17767909"]}, {"Citation": "Bai Y., Zhu R., Tian Y., Li R., Chen B., Zhang H., Xia B., Zhao D., Mo F., Zhang D., et al. Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety. Molecules. 2019;24:3302. doi: 10.3390/molecules24183302.", "ArticleIdList": ["10.3390/molecules24183302", "PMC6767014", "31514313"]}, {"Citation": "Yan J., Wang C., Jin Y., Meng Q., Liu Q., Liu Z., Liu K., Sun H. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway. Pharmacol. Res. 2018;130:466\u2013480. doi: 10.1016/j.phrs.2017.12.026.", "ArticleIdList": ["10.1016/j.phrs.2017.12.026", "29284152"]}, {"Citation": "Bao Q., Shen X., Qian L., Gong C., Nie M., Dong Y. Anti-diabetic activities of catalpol in db/db mice. Korean J. Physiol. Pharmacol. 2016;20:153\u2013160. doi: 10.4196/kjpp.2016.20.2.153.", "ArticleIdList": ["10.4196/kjpp.2016.20.2.153", "PMC4770105", "26937211"]}, {"Citation": "Liu J., Zhang H.R., Hou Y.B., Jing X.L., Song X.Y., Shen X.P. Global gene expression analysis in liver of db/db mice treated with catalpol. Chin. J. Nat. Med. 2018;16:590\u2013598. doi: 10.1016/S1875-5364(18)30096-7.", "ArticleIdList": ["10.1016/S1875-5364(18)30096-7", "30197124"]}, {"Citation": "Trembath D.G. Chapter 26-Molecular Testing for Glioblastoma. In: Coleman W.B., Tsongalis G.J., editors. Diagnostic Molecular Pathology. Academic Press; Cambridge, MA, USA: 2017. pp. 339\u2013347."}, {"Citation": "Kim Y., Kim E.Y., Seo Y.M., Yoon T.K., Lee W.S., Lee K.A. Function of the pentose phosphate pathway and its key enzyme, transketolase, in the regulation of the meiotic cell cycle in oocytes. Clin. Exp. Reprod. Med. 2012;39:58\u201367. doi: 10.5653/cerm.2012.39.2.58.", "ArticleIdList": ["10.5653/cerm.2012.39.2.58", "PMC3398118", "22816071"]}, {"Citation": "Wang Y., Jiang Z.-T., Li R. Antioxidant Activity, Free Radical Scavenging Potential and Chemical Composition of Litsea cubeba Essential Oil. J. Essent. Oil-Bear. Plants JEOP. 2012;15:134\u2013143. doi: 10.1080/0972060X.2012.10644029.", "ArticleIdList": ["10.1080/0972060X.2012.10644029"]}, {"Citation": "Sousa C., Leit\u00e3o A.J., Neves B.M., Judas F., Cavaleiro C., Mendes A.F. Standardised comparison of limonene-derived monoterpenes identifies structural determinants of anti-inflammatory activity. Sci. Rep. 2020;10:7199. doi: 10.1038/s41598-020-64032-1.", "ArticleIdList": ["10.1038/s41598-020-64032-1", "PMC7190660", "32350292"]}, {"Citation": "Nazzaro F., Fratianni F., De Martino L., Coppola R., De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals. 2013;6:1451\u20131474. doi: 10.3390/ph6121451.", "ArticleIdList": ["10.3390/ph6121451", "PMC3873673", "24287491"]}, {"Citation": "Boskabady M.H., Jandaghi P. Relaxant effects of carvacrol on guinea pig tracheal chains and its possible mechanisms. Pharmazie. 2003;58:661\u2013663.", "ArticleIdList": ["14531466"]}, {"Citation": "Brum L.F., Elisabetsky E., Souza D. Effects of linalool on [(3)H]MK801 and [(3)H] muscimol binding in mouse cortical membranes. Phytother. Res. 2001;15:422\u2013425. doi: 10.1002/ptr.973.", "ArticleIdList": ["10.1002/ptr.973", "11507735"]}, {"Citation": "Koroch A.R., Rodolfo Juliani H., Zygadlo J.A. Bioactivity of Essential Oils and Their Components. In: Berger R.G., editor. Flavours and Fragrances: Chemistry, Bioprocessing and Sustainability. Springer; Berlin/Heidelberg, Germany: 2007. pp. 87\u2013115."}, {"Citation": "Wojdy\u0142o A., Oszmia\u0144ski J., Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007;105:940\u2013949. doi: 10.1016/j.foodchem.2007.04.038.", "ArticleIdList": ["10.1016/j.foodchem.2007.04.038"]}, {"Citation": "Zunino M.P., Zygadlo J.A. Effect of monoterpenes on lipid oxidation in maize. Planta. 2004;219:303\u2013309.", "ArticleIdList": ["14986141"]}, {"Citation": "Javan A.J., Javan M.J. Electronic structure of some thymol derivatives correlated with the radical scavenging activity: Theoretical study. Food Chem. 2014;165:451\u2013459. doi: 10.1016/j.foodchem.2014.05.073.", "ArticleIdList": ["10.1016/j.foodchem.2014.05.073", "25038698"]}, {"Citation": "Malmir M., Gohari A.R., Saeidnia S., Silva O. A new bioactive monoterpene-flavonoid from Satureja khuzistanica. Fitoterapia. 2015;105:107\u2013112. doi: 10.1016/j.fitote.2015.06.012.", "ArticleIdList": ["10.1016/j.fitote.2015.06.012", "26086672"]}, {"Citation": "Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013;93:137\u2013188. doi: 10.1152/physrev.00045.2011.", "ArticleIdList": ["10.1152/physrev.00045.2011", "23303908"]}, {"Citation": "Patel D.K., Kumar R., Laloo D., Hemalatha S. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac. J. Trop. Biomed. 2012;2:411\u2013420. doi: 10.1016/S2221-1691(12)60067-7.", "ArticleIdList": ["10.1016/S2221-1691(12)60067-7", "PMC3609313", "23569941"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "14"}, {"Year": "2021", "Month": "12", "Day": "20"}, {"Year": "2021", "Month": "12", "Day": "25"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "1", "Minute": "14"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35011414", "PMC8746715", "10.3390/molecules27010182", "molecules27010182"]}}], "PubmedBookArticle": []}